Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world.
Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world-leader in NGS services, with 2,600 employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 29 NGS-related patents, as well as over 4920 research papers, including publications in first tiers journals such as Cell, Nature and Science.
A privately-owned institution headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).
Advancing Genomics, Improving Life
To be the Global Leader in Providing Genomic Services and Solutions
Professionalism, Innovation, Integrity, Partnership
Company founder, Dr. Ruiqiang Li
Dr. Ruiqiang Li, is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 17 patents and has authored over 100 publications that have been cited more than 42,000 times. Best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused the company on being a full-service provider, performing NGS services and providing bioinformatic analysis to fully empower and enable our customers to move forward rapidly and effectively in their scientific endeavors.
We help our customers achieve their objectives by offering:
Our informatics expertise and strict adherence to quality control enable us to offer an industry-leading Q30 guarantee that exceeds even Illumina’s own official Q30 guidelines. This results in the highest quality data, unsurpassed by any other NGS service provider.
With Dr. Li’s expertise, bioinformatics scientists and standard sample automatic bioinformatics analysis system, we give our customers “publication-ready data”.
Using our array of state-of-the-art Illumina systems (NovaSeq 6000, HiSeq X Ten, HiSeq 4000, and HiSeq 2500), PacBio Sequel system, Oxford Nanopore PromethION and Thermo Fisher Ion proton , we select the most effective system for our customers’ needs.
Our large assembly of NGS systems enables us to run projects of any size, including those that require massive amounts of sequencing and analysis.
We complete projects faster than local cores and the vast majority of service providers due to our scientific acumen (65% of our employees have advanced degrees) and NGS capacity.
Jan Vijg, Ph.D.
Professor and Department Chair, Department of Genetics, Albert Einstein College of Medicine, New York, USA
“I have been getting great results with Novogene NGS for a wide variety of samples; ranging from highly degraded, ancient animal DNA samples to longer, fresh human DNA samples. Their rapid turn-around time keeps our projects moving at a fast pace and they have quick-to-respond, expert support when required.”
Tim Heupink, Ph.D.
Research Fellow, Environmental Futures Research Institute, Griffith University, Brisbane, Australia
Nanjing Sequencing Center
Joint Venture & Singapore Sequencing Center
Tianjin Sequencing Center & CAP Certified Clinical Lab
Cambridge Sequencing Center
UC Davis Sequencing Center & CLIA Certified Clinical Lab
Novogene is an Illumina Genome Network partner that has done work for many of the largest and most prestigious institutions around the world. Having completed more than 1,259,000 projects with a total data output of over 21,476 TB, Novogene has a track record of performance and reliability and more advanced NGS capacity in the world. We’ve proudly served over 4,000 customers globally, collaborating with scientists in 60 countries and regions. We offer a range of NGS-based services for human, plant, animal and microbial DNA and RNA analysis at highly competitive prices.